Fisher, R., Das, S., Gorthi, A., Tran, B. N., Tamakloe, T., O'Brien, C., Sawaengsri, H., Gowen, K., Cibulskis, K., Gardner, H. A., Painter, C., D'Ippolito, A., Eaton, M. L., Stroh, C., Machl, A., Kloetgen, A., Feng, Z., Barrett, J. C. (2026). Comprehensive plasma-based epigenomic profiling from INTR@PID Lung 037 study samples to identify pathways associated with response and resistance to pembrolizumab in PD-L1–high NSCLC.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e20547